Surv BioPharma

Kagoshima, Japan · Founded 2022 · Privately Held (backing)

Developer of gene therapies designed to improve the treatment of various diseases. Surv BioPharma is based in Kagoshima, Japan and was founded in 2022. Its last reported valuation was $32.5 million in Dec 2025. It has raised $21.3 million.

Last reported valuation

$32.5M

Oct 2026

Priced at

—

Total raised

$21.3M

Last round

—

How much has Surv BioPharma raised?

$21.3Macross 0 recorded rounds

Free account

More of Surv BioPharma with a free account

·The complete investor list: 15 names
·Watch Surv BioPharma: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Surv BioPharma investors

15 investors are on record for Surv BioPharma, including Nippon Venture Capital, FFG Venture Business Partners, Keio Innovation Initiative and Kyoto University Innovation Capital.

For fundraisers

Raising for a company like Surv BioPharma?

15 investors have backed Surv BioPharma.

See all 15 investors →

Frequently asked about Surv BioPharma

How much has Surv BioPharma raised?: Surv BioPharma has raised $21.3M in total across 0 recorded funding rounds.